Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort

BACKGROUND: The aim of the study was to analyze the relationship between pretreatment inflammatory biomarkers (IBs) and survival outcomes for patients with esophageal squamous cell carcinoma (ESCC) treated with neoadjuvant chemoradiotherapy (neo‐CRT) and pembrolizumab. METHODS: Clinical variables an...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Wei‐Xiang, Wang, Xiaoyan, Li, Chengqiang, Li, Shuyan, Li, Huan, Xu, Feifei, Chen, Jiayi, Zhao, Shengguang, Li, Hecheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260499/
https://www.ncbi.nlm.nih.gov/pubmed/37089116
http://dx.doi.org/10.1111/1759-7714.14898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260499/
https://www.ncbi.nlm.nih.gov/pubmed/37089116
http://dx.doi.org/10.1111/1759-7714.14898

Ejemplares similares